Delirium-Prevention Program for Postoperative Delirium
(PROMoTE Trial)
Trial Summary
What is the purpose of this trial?
Cognitive complications, that is problems with thinking and memory, are incredibly common after surgery, occurring in 10-50% of all older surgical patients. These complications can take different forms, but one of the most common is postoperative delirium (POD), a short-term state of confusion. In addition to being stressful for patients and their families, POD is linked to longer hospital stays, increased costs, higher mortality rates and other problems after surgery. Despite this, POD is often not recognized by doctors and there are currently no effective medications to treat POD. However, simple strategies such as helping patients to sleep properly and remain hydrated, have been shown to help. This study is testing if a delirium-reduction program will reduce postoperative delirium (POD) in older surgical patients. The investigators will first test memory and thought processes before surgery to find people who are most likely to develop POD. Once these people have been identified, they will be enrolled in a program which includes recommendations for their care team (e.g. surgeon, anesthesiologist, nurses) as well as educational materials for them and their family related to things that can be done to prevent delirium. By identifying at-risk patients and making sure that their doctors and caregivers are aware of how to prevent delirium, the investigators expect that this study will make surgery safer for older surgical patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Multicomponent delirium-risk prevention bundle for preventing postoperative delirium?
Is the Delirium-Prevention Program safe for humans?
How is the Delirium-Prevention Program different from other treatments for postoperative delirium?
The Delirium-Prevention Program is unique because it uses a multicomponent approach, combining several strategies to reduce the risk of delirium after surgery, rather than relying on a single method or medication. This comprehensive bundle may include elements like cognitive exercises, environmental adjustments, and medication management, making it distinct from treatments that focus solely on drugs or single interventions.7891011
Research Team
Stephen Choi, MD
Principal Investigator
Sunnybrook Health Sciences Centre
Eligibility Criteria
This trial is for older adults (60+) who are having major elective surgery with a hospital stay of at least one night and show signs of cognitive impairment on initial tests. It's not for those undergoing heart or brain surgery, with substance use disorders, or who may not follow the study plan.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Phase I
Establish the prevalence of POD and pre-CI in the patient population and act as a control group for Phase II
Phase II
Evaluate the effects of a comprehensive delirium-risk prevention bundle, including direct-to-patient education and healthcare provider awareness strategies
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Multicomponent delirium-risk prevention bundle (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sunnybrook Health Sciences Centre
Lead Sponsor